ChemicalBook > CAS DataBase List > LY 267108

LY 267108

Product Name
LY 267108
CAS No.
105882-69-7
Chemical Name
LY 267108
Synonyms
LY 267108;Erythromycin Imp F;Erythromycin impurity 06;NMIWBQUQCOMGHJ-XWVSLMRSSA-N;Erythromycin Ethyl succinate Impurity F;Pseudo erythromycin A enol ether, EvoPure;8,9-Anhydropseudo-erythroMycin A-6,9-heMiketal;Erythromycin Impurity 15(Erythromycin EP Impurity F);Erythromycin Impurit F:(pseudoerythromycin A enol ether);Erythromycin EP Impurity F (Pseudo Erythromycin A Enol Ether)
CBNumber
CB71348120
Molecular Formula
C37H65NO12
Formula Weight
715.91
MOL File
105882-69-7.mol
More
Less

LY 267108 Property

Melting point:
127.0-130.0 °C
Boiling point:
810.7±65.0 °C(Predicted)
Density 
1.20±0.1 g/cm3(Predicted)
storage temp. 
−20°C
solubility 
DMF: Soluble; DMSO: Soluble; Ethanol: Soluble; Methanol: Soluble
pka
13.45±0.70(Predicted)
More
Less

Safety

WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
38874
Product name
Pseudoerythromycin A enol ether
Purity
analytical standard
Packaging
5mg
Price
$639
Updated
2024/03/01
Cayman Chemical
Product number
15508
Product name
Pseudoerythromycin A enol ether
Purity
≥98%
Packaging
1mg
Price
$98
Updated
2024/03/01
Cayman Chemical
Product number
15508
Product name
Pseudoerythromycin A enol ether
Purity
≥98%
Packaging
5mg
Price
$294
Updated
2024/03/01
American Custom Chemicals Corporation
Product number
API0045939
Product name
PSEUDOERYTHROMYCIN A ENOL ETHER
Purity
95.00%
Packaging
5MG
Price
$503.15
Updated
2021/12/16
More
Less

LY 267108 Chemical Properties,Usage,Production

Chemical Properties

White Solid

Uses

Pseudo Erythromycin A Enol Ether (Erythromycin EP Impurity F) is an Erythromycin impurity.

Uses

Erythromycin impurity.

Uses

Pseudoerythromycin A enol ether is a degradation product of erythromycin formed by a complex internal rearrangement of erythromycin A on exposure to neutral to weakly alkaline conditions. The C6–OH forms an internal enol ether with the C9 ketone of erythromycin, while the C11-OH attacks the carbonyl of the lactone to reduce the macrocycle from a 14- to an 11-membered macrolide. Synthetically, pseudoerythromycin A enol ether is prepared by reacting erythromycin enol ether with carbonate. Pseudoerythromycin A enol ether is devoid of antibiotic activity but is an important analytical standard for erythromycin A stability studies.

LY 267108 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

LY 267108 Suppliers

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
94838
Advantage
76
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
32344
Advantage
50
Beijing Comparison Pharmaceutical Technology Co., Ltd
Tel
010-52878169 15701683040
Email
sales@bjcomparison.com
Country
China
ProdList
4689
Advantage
58
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Fax
0755-28363542
Email
sales@chem-strong.com
Country
China
ProdList
17981
Advantage
56
Lynnchem
Tel
86-(0)29-85992781 17792393971
Email
info@lynnchem.com
Country
China
ProdList
4587
Advantage
58
Novachemistry
Tel
44-20819178-90 02081917890
Fax
(0)2080432064
Email
info@novachemistry.com
Country
United Kingdom
ProdList
4381
Advantage
58
Shanghai Hongye Biotechnology Co. Ltd
Tel
400-9205774
Email
sales@glpbio.cn
Country
China
ProdList
6870
Advantage
58
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel
+86-400-002-6226 13028896684
Email
sales@rrkchem.com
Country
China
ProdList
55827
Advantage
58
Shenzhen Botel Biotechnology Co. Ltd.
Tel
0755-22202135 13316968096
Email
1979313431@qq.com
Country
China
ProdList
7726
Advantage
58
Chengdu MassCale Pharmaceutical Co., Ltd.
Tel
028-84552636 18084815636
Email
chensfsc@126.com
Country
China
ProdList
1448
Advantage
58

105882-69-7, LY 267108Related Search:


  • LY 267108
  • (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-Dideoxy-3-C-Methyl-3-O-Methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-Methylbutyl]-2,6,8,10,12-pentaMethyl-9-[[3,4,6-trideoxy-3-(diMethylaMino)-β-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-12-en-5-one
  • 8,9-Anhydropseudo-erythroMycin A-6,9-heMiketal
  • (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-12-en-5-one
  • NMIWBQUQCOMGHJ-XWVSLMRSSA-N
  • Erythromycin EP Impurity F/(2R,3R,6R,7S,8S,9R,10R)-3-((2R,3R)-2,3-dihydroxypentan-2-yl)-9-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,6
  • Erythromycin Impurit F:(pseudoerythromycin A enol ether)
  • Erythromycin Impurity 15(Erythromycin EP Impurity F)
  • Erythromycin Ethyl succinate Impurity F
  • 4,13-Dioxabicyclo[8.2.1]tridec-12-en-5-one, 7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (2R,3R,6R,7S,8S,9R,10R)-
  • Erythromycin Imp F
  • Erythromycin EP Impurity F (Pseudo Erythromycin A Enol Ether)
  • Erythromycin impurity 06
  • Pseudo erythromycin A enol ether, EvoPure
  • (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D- xylohexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-1(12)-en-5- one
  • 105882-69-7
  • Intermediates & Fine Chemicals
  • Metabolites & Impurities
  • Pharmaceuticals
  • Chromatography
  • Drugs&Metabolites
  • Forensic and Veterinary Standards
  • Neat CompoundsAnalytical Standards
  • Pharmacology Standards